NEW YORK--(BUSINESS WIRE)--MTS Health Investors, LLC, a healthcare-focused private equity firm, announced that it has completed the sale of its portfolio company, Woodbury Holdings, to ConvaTec Group Plc. Terms of the transaction were not disclosed.
Based in Floral Park, NY, Woodbury provides an extensive array of incontinence and catheter products, as well as nutritional, enteral feeding, and vascular compression supplies. The Company has national distribution across the U.S., delivering directly to customers in the home environment. MTS completed its majority investment in Woodbury in March of 2012.
“The sale of Woodbury to ConvaTec creates an exceptional outcome for both companies’ customers, while also delivering a terrific outcome for our investors,” said Oliver Moses, Senior Managing Director of MTS. “We are proud to have been able to execute on our strategy with Woodbury’s leadership and deliver the business to a new partner who will continue to support the excellent clinical products and customer service that Woodbury provides.”
“MTS has been an outstanding partner for Woodbury, and we are grateful for their commitment to improving and growing our business,” said Seth Segel, CEO of Woodbury. “By partnering with ConvaTec, we will have access to even greater resources backed by a robust infrastructure to serve our customers and continue to provide them with the tailored and seamless solutions they depend on.”
Robert W. Baird & Co. served as sole financial advisor, and Hogan Lovells, LLP served as legal advisor to Woodbury on the transaction.
MTS Health Investors, LLC ("MTS") makes equity investments in companies that operate within the services sectors of the healthcare industry. MTS focuses on companies with profitable business models and a demonstrated ability to deliver cost-effective solutions. MTS manages over $700 million in investments and is currently investing out of its fourth fund. MTS is based in New York City and invests in companies throughout the United States.